Figure 8

(a) Distribution of SSR markers among genomic, cDNA and coding sequences of PRGs (b) Abundance of mono-, di-, tri-, tetra-, penta-nucleotide repeats and compound SSRs in genomic sequences of PRGs. (c) Number of SSRs discovered from genomic, cDNA and coding sequences of various PRGs.